...
首页> 外文期刊>Mayo Clinic Proceedings >Effectiveness and safety of short-course vs long-course antibiotic therapy for group a beta hemolytic streptococcal tonsillopharyngitis: a meta-analysis of randomized trials.
【24h】

Effectiveness and safety of short-course vs long-course antibiotic therapy for group a beta hemolytic streptococcal tonsillopharyngitis: a meta-analysis of randomized trials.

机译:短程与长程抗生素治疗β组溶血性链球菌扁桃体咽喉炎的有效性和安全性:一项随机试验的荟萃分析。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To evaluate the effectiveness and safety of short-course antibiotic treatment of group A beta-hemolytic streptococcal (GAS) tonsillopharyngitis. METHODS: We performed a meta-analysis of randomized controlled trials (RCTs) retrieved from PubMed and the Cochrane Central Register of Controlled Trials using a structured search strategy. The last date either database was accessed was November 14, 2007. We included RCTs that involved patients of any age with GAS tonsillopharyngitis, comparing short-course (< or =7 days) vs long-course (at least 2 days longer than short-course) treatment with the same antibiotics. The primary analysis compared 5 to 7 days with 10 days of treatment, using a random effects model. RESULTS: Eleven RCTs comparing short-course vs long-course treatment (5 with penicillin V, 4 with oral cephalosporins, 1 with intramuscular ceftriaxone, and 1 with clindamycin; 6 of the 11 were open label) were included. In the primary analysis, microbiological eradication rates of GAS were inferior for short-course vs long-course treatment (8 RCTs, 1607 patients; odds ratio [OR], 0.49; 95% confidence interval [CI], 0.32-0.74). This association was noted with penicillin V treatment (3 RCTs, 500 patients; OR, 0.36; 95% CI, 0.13-0.99) but was nonsignificant with cephalosporin treatment (4 RCTs, 1018 patients; OR, 0.62; 95% CI, 0.38-1.03). Microbiological eradication was less likely with short-course treatment in trials involving primarily children and adolescents (aged <18 years) (6 RCTs, 1258 patients; OR, 0.63; 95% CI, 0.40-0.98). Clinical success was inferior in patients who received short-course treatment (5 RCTs, 1217 patients; OR, 0.49; 95% CI, 0.25-0.96). Adverse events did not differ between compared groups. The above associations were consistent in the analyses involving all included RCTs. CONCLUSION: Short-course treatment for GAS tonsillopharyngitis, particularly with penicillin V, is associated with inferior bacteriological eradication rates.
机译:目的:评估短程抗生素治疗A组β-溶血性链球菌(GAS)扁桃体咽喉炎的有效性和安全性。方法:我们使用结构化搜索策略对从PubMed和Cochrane对照试验中央注册簿中检索到的随机对照试验(RCT)进行了荟萃分析。访问这两个数据库的最后日期是2007年11月14日。我们纳入了涉及所有年龄段的GAS扁桃体咽喉炎患者的RCT,比较了短疗程(<或= 7天)与长疗程(至少短于2天)当然)用相同的抗生素治疗。初步分析使用随机效应模型将5到7天与10天的治疗进行了比较。结果:包括11个随机对照试验,比较了短期和长期治疗(青霉素V 5例,口服头孢菌素4例,肌内头孢曲松1例,克林霉素1例; 11例用开放标签)。在初步分析中,短期和长期治疗相比,GAS的微生物根除率较低(8例RCT,1607例患者;优势比[OR]为0.49; 95%置信区间[CI]为0.32-0.74)。青霉素V治疗(3例RCT,500例患者; OR,0.36; 95%CI,0.13-0.99)与这种关联被发现,头孢菌素治疗(4例RCT,1018例患者; OR,0.62; 95%CI,0.38- 1.03)。在主要涉及儿童和青少年(年龄小于18岁)的试验中,短期治疗的微生物根除可能性较小(6个RCT,1258例患者; OR,0.63; 95%CI,0.40-0.98)。接受短程治疗的患者的临床成功率较差(5例RCT,1217例; OR,0.49; 95%CI,0.25-0.96)。两组之间的不良事件没有差异。上述关联在涉及所有纳入的RCT的分析中是一致的。结论:GAS扁桃体咽炎的短程治疗,尤其是青霉素V,与细菌根除率低有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号